Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study. En savoir plus sur Prognostic Value of Baseline Neutrophil-to-Lymphocyte Ratio in Metastatic Urothelial Carcinoma Patients Treated With First-line Chemotherapy: A Large Multicenter Study.
Efflux pump ABCB1 single nuClinique eotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib. En savoir plus sur Efflux pump ABCB1 single nuClinique eotide polymorphisms and dose reductions in patients with metastatic renal cell carcinoma treated with sunitinib.
Alternative prescription schedules of sunitinib in metastatic kidney cancer: from the underground to the light? En savoir plus sur Alternative prescription schedules of sunitinib in metastatic kidney cancer: from the underground to the light?
A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study. En savoir plus sur A phase II trial of high-dose chemotherapy (HDCT) supported by hematopoietic stem-cell transplantation (HSCT) in germ-cell tumors (GCTs) patients failing cisplatin-based chemotherapy: the Multicentric TAXIF II study.
A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study En savoir plus sur A risk-adapted study of cisplatin and etoposide, with or without ifosfamide, in patients with metastatic seminoma: results of the GETUG S99 multicenter prospective study